So, double DNMT3A and DNMT3B knocking down needs to be further performed in order to better explore the biological and molecular effects exerted by the concomitant absence of the two enzymes in ERMS cellular context and to set up the best conditions to strongly impact cancer cell proliferation, programmed death and differentiative rescue. The gene discussed is DNMT3B; the disease is cancer.